Exosomal miR‐1169 and miR‐260 were identified as potential candidates, which contain specific characteristics that can distinguish between wild‐type EGFR and mutant EGFR NSCLC patients in early‐stage cancers. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.